The World Health Organisation (WHO) Study Reveals That CBD Is Generally Safe In Humans
In the UK to date, their is no officially launched guideline on the safety of Cannabidiol in humans, however there are a couple of resources that can shed some light.
The FSA has highlighted that above a certain dosage, side effects of CBD can affect the liver and has advised that a safe max dose of 28 drops (approximately 70mg) of a 500mg product be adhered to.
The World Health Organisation in its study has listed CBD generally as a safe product and their statement is as follows:
Adverse Reactions in Humans
As noted above, CBD does not produce the effects that are typically seen with
cannabinoids such as THC. It also failed to produce significant effects in a human
study of abuse potential discussed below.  Across a number of controlled and open
label trials CBD of the potential therapeutic effects of CBD it is generally well
tolerated, with a good safety profile. [39, 53] Clinical trials involving use of CBD for
treatment of epilepsy will be discussed in Section 9: Therapeutic Applications.
These findings should give consumers confidence in the safety of Cannabidiol and be able to supplement their diet for the added benefits it brings.
Please note that this article was written by a 3rd-party author who is a specialist on the topic of CBD, hemp and cannabis. Any information or recommendations contained within this article, are independent to the opinion of RUDERALEX CBD and our employees. We make no claims for any of our products, please read our disclaimer for additional information.